SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 262.68 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 1,265.22 |
| Book Value / Share | 41.66 |
| Price / Book | n/a |
| NCAV ($M) | 151.74 |
| NCAV / Share | 5.00 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.01 |
| Return on Assets (ROA) | 0.01 |
| Return on Equity (ROE) | 0.01 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.28 |
| Current Ratio | 10.22 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 959.13 |
| Assets | 2,072.61 |
| Liabilities | 807.39 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| MIXX – Mix1 Life, Inc. | MLLCF – Molecular Partners AG |
| MLPH – Molecular Pharmacology (USA), Ltd. | MRMD – MariMed Inc. |
| MSLPQ – MusclePharm Corporation |
Financial data and stock pages provided by
Fintel.io